Delivery Order SPE2DB24D1205-SPE2DB25FCZSJ
- Not listed
- The U.S. Defense Medical Supply Chain awarded a firm fixed price delivery order valued at $2,141.90 to AmerisourceBergen Drug Corp for Tubersol 5T Unit/0.1 ML Vial 5ML, a tuberculosis skin test antigen. The order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This non-set-aside award represents a competitively awarded delivery order under AmerisourceBergen's existing contract...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for $1,155.00 to supply TUBERSOL 5T UNIT/0.1 ML VIAL tuberculosis skin test antigen. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,208.60, is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 19, 2024. The contract was awarded on November 18, 2024 and does not have a set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Tubersol 5T Unit/0.1 ML Vial 5ML with a ceiling value of $1,069.88 under a firm fixed-price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and no set-aside designation was utilized. Performance will be conducted at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $2,089.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561852016 TUBERSOL 5T UNIT/0.1 ML VIAL 5ML. The place of performance is Conshohocken, Pennsylvania. The start date is August 17, 2023 and end date is August 18, 2023. The Defense Logistics Agency supports military readiness by procuring, managing and providing supplies to the armed forces. This delivery order is likely associated with the Agency's stockpile of vaccines...
- This federal contract award, with ID SPE2DB20D2002|SPE2DB25FL39N, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,850.32 firm fixed-price delivery order is for the supply of 4,568,092,129 units of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, with a performance period ending on May 1, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,683.44 order is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML pharmaceutical products to support DLA Troop Support Medical programs and facilities. No set aside designation was used for this contract. Amerisourcebergen Drug Corp has an extensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $19,718.70 firm-fixed price delivery order is for the supply of Tubersol, a medical product used for tuberculosis testing. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, with a firm fixed price of $2,141.90 and an ultimate completion date of May 13, 2025. The contract is not set aside and allows for the delivery of a wide range of pharmaceutical and medical products to support military and government...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,710.88, is for the supply of Tubersol 5T Unit/0.1 ML Vial ML, a tuberculosis test product. The contract is a firm fixed-price delivery order, with an ultimate completion date of July 18, 2024. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp, through its Corporate Office Division, has been...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZSJDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,179.04 on August 19, 2025, for the supply of Tubersol 5T Unit/0.1 mL vial 5mL tuberculin skin test antigen. This firm fixed price, non-set-aside contract is scheduled for completion by August 20, 2025, with performance at the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in federal medical procurement through its extensive portfolio with the Defense Logistics Agency and Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government entities. All of the company's reviewed contract awards are competitively awarded non-set-asides with firm fixed pricing, demonstrating its capability to meet federal procurement requirements through open competition. This particular delivery order for tuberculin antigen represents a routine procurement transaction supporting medical testing capabilities across the federal health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/19/25 |